Logo image of CHR.CA

CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CHR - CA17040T8885 - Common Stock

21.97 CAD
+0.04 (+0.18%)
Last: 11/27/2025, 7:00:00 PM
Fundamental Rating

4

CHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 7 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CHR had positive earnings in the past year.
In the past year CHR had a positive cash flow from operations.
In multiple years CHR reported negative net income over the last 5 years.
In the past 5 years CHR always reported a positive cash flow from operatings.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -2.62%, CHR perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
With a decent Return On Equity value of -6.31%, CHR is doing good in the industry, outperforming 71.43% of the companies in the same industry.
The Return On Invested Capital of CHR (6.40%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 5.26%.
The last Return On Invested Capital (6.40%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROIC 6.4%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

CHR has a better Operating Margin (6.81%) than 71.43% of its industry peers.
In the last couple of years the Operating Margin of CHR has declined.
CHR has a Gross Margin of 65.68%. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
Industry RankSector Rank
OM 6.81%
PM (TTM) N/A
GM 65.68%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CHR has less shares outstanding
Compared to 5 years ago, CHR has more shares outstanding
CHR has a better debt/assets ratio than last year.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.95, we must say that CHR is in the distress zone and has some risk of bankruptcy.
CHR has a Altman-Z score of 0.95. This is comparable to the rest of the industry: CHR outperforms 42.86% of its industry peers.
The Debt to FCF ratio of CHR is 10.63, which is on the high side as it means it would take CHR, 10.63 years of fcf income to pay off all of its debts.
CHR has a Debt to FCF ratio of 10.63. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.50, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Altman-Z 0.95
ROIC/WACC0.77
WACC8.31%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.22 indicates that CHR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.22, CHR is in line with its industry, outperforming 57.14% of the companies in the same industry.
A Quick Ratio of 0.63 indicates that CHR may have some problems paying its short term obligations.
CHR has a Quick ratio (0.63) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.63
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

CHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.86%, which is quite impressive.
CHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
Looking at the last year, CHR shows a decrease in Revenue. The Revenue has decreased by -8.40% in the last year.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%

3.2 Future

Based on estimates for the next years, CHR will show a small growth in Earnings Per Share. The EPS will grow by 6.05% on average per year.
The Revenue is expected to decrease by -4.27% on average over the next years.
EPS Next Y55.58%
EPS Next 2Y13.32%
EPS Next 3Y6.05%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.78%
Revenue Next 3Y-4.27%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.04, the valuation of CHR can be described as reasonable.
Based on the Price/Earnings ratio, CHR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CHR to the average of the S&P500 Index (26.15), we can say CHR is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.33, the valuation of CHR can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CHR is valued cheaper than 85.71% of the companies in the same industry.
CHR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.12.
Industry RankSector Rank
PE 9.04
Fwd PE 11.33
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CHR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CHR is cheaper than 71.43% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR indicates a somewhat cheap valuation: CHR is cheaper than 71.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.23
EV/EBITDA 4.17
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y13.32%
EPS Next 3Y6.05%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.48%, CHR has a reasonable but not impressive dividend return.
CHR's Dividend Yield is comparable with the industry average which is at 2.53.
CHR's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 1 2 3

5.3 Sustainability

CHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
CHR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-5.89%
EPS Next 2Y13.32%
EPS Next 3Y6.05%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR (11/27/2025, 7:00:00 PM)

21.97

+0.04 (+0.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap559.80M
Revenue(TTM)1.35B
Net Income(TTM)-34.96M
Analysts78
Price Target30.26 (37.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-12 2025-12-12 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)5.79%
PT rev (3m)5.79%
EPS NQ rev (1m)7.14%
EPS NQ rev (3m)5%
EPS NY rev (1m)0.17%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.04
Fwd PE 11.33
P/S 0.41
P/FCF 17.23
P/OCF 7.86
P/B 1.01
P/tB 1.03
EV/EBITDA 4.17
EPS(TTM)2.43
EY11.06%
EPS(NY)1.94
Fwd EY8.83%
FCF(TTM)1.28
FCFY5.8%
OCF(TTM)2.79
OCFY12.72%
SpS52.96
BVpS21.76
TBVpS21.41
PEG (NY)0.16
PEG (5Y)N/A
Graham Number34.49
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROCE 8.63%
ROIC 6.4%
ROICexc 6.56%
ROICexgc 6.62%
OM 6.81%
PM (TTM) N/A
GM 65.68%
FCFM 2.41%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Debt/EBITDA 1.32
Cap/Depr 32.58%
Cap/Sales 2.87%
Interest Coverage 2.74
Cash Conversion 33.79%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.63
Altman-Z 0.95
F-Score6
WACC8.31%
ROIC/WACC0.77
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
EPS Next Y55.58%
EPS Next 2Y13.32%
EPS Next 3Y6.05%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
Revenue Next Year-4.85%
Revenue Next 2Y-3.78%
Revenue Next 3Y-4.27%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year86.18%
EBIT Next 3Y12.53%
EBIT Next 5YN/A
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.


What is the valuation status for CHR stock?

ChartMill assigns a valuation rating of 7 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Undervalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.


What are the PE and PB ratios of CHORUS AVIATION INC (CHR.CA) stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 9.04 and the Price/Book (PB) ratio is 1.01.


What is the expected EPS growth for CHORUS AVIATION INC (CHR.CA) stock?

The Earnings per Share (EPS) of CHORUS AVIATION INC (CHR.CA) is expected to grow by 55.58% in the next year.